About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 19,079 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 19,079 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1081-1100 of 19,079 trials

RecruitingDALY II USA/ MB-CART2019.1 for DLBCLDALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with…NCT04792489·Birmingham, Alabama and 31 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedSafety and Tolerability Extension Trial for Patients With Chronic Idiopathic ConstipationSafety and Tolerability Extension Trial for Patients with Chronic Idiopathic Constipation (CIC)NCT01895543·Tucson, Arizona and 61 others

CompletedAMPLEX Ankle Fusion and HindfootTo demonstrate that AMPLEX is non-inferior to autogenous bone graft (ABG) for bone fusion in a population indicated for single, double, or triple hindfoot arthrodesis or ankle…NCT03028415·Gilbert, Arizona and 35 others

CompletedDabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous MelanomaThis was a two-arm, open-label, randomized, Phase III study comparing dabrafenib (GSK2118436) and trametinib (GSK1120212) combination therapy with vemurafenib.NCT01597908·Birmingham, Alabama and 204 others

CompletedA Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple SclerosisThis study will evaluate the pharmacokinetics, pharmacodynamics, safety, immunogenicity, and radiological and clinical effects of subcutaneous (SC) administration of ocrelizumab…NCT05232825·Maitland, Florida and 36 others

Active not recruitingDiabetes Medical Nutrition Therapy in Southeastern African American WomenA two-arm randomized controlled trial design will be used.NCT04971889·Nashville, Tennessee and 1 other

CompletedHyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaThe registry is a multi-center, prospective, observational study designed to collect data in patients with euvolemic and hypervolemic hyponatremia in the hospital setting in the…NCT01240668·Azusa, California and 78 others

CompletedA Natural History Study of Patients With Dry EyeThis is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.NCT00833235·Little Rock, Arkansas and 16 others

CompletedTreatment for Teachers With Vocal FatigueTeachers are a population at high risk for voice disorders given their occupational demands.NCT04486989·Johnson City, Tennessee

CompletedLBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer PatientsThis single center Phase I dose escalation trial will evaluate the safety, tolerability and efficacy of LBH589 when combined with capecitabine and lapatinib in three parts.NCT00632489·Nashville, Tennessee

CompletedSibutramine to Reduce Weight Gain and Improve Smoking Cessation RatesThe purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.NCT00037752·Memphis, Tennessee

CompletedSafety and Tolerability Study of IV ST266 in COVID-19 SubjectsThe primary aim of the study is to evaluate the safety and tolerability of open-label ST266 given to subjects with confirmed COVID-19 infection through IV administration once a…NCT04720378·Clearwater, Florida and 2 others

Active not recruitingA Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)The purpose of this study is to assess the safety and efficacy of Navlimetostat (BMS-986504), a selective, MTA-cooperative PRMT5 inhibitor, in combination with…NCT07076121·Phoenix, Arizona and 268 others

CompletedStudy of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderThe purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.NCT00046384·Scottsdale, Arizona and 13 others

CompletedA Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsThe primary purpose of this study is to evaluate the efficacy of the study drug known as LY2875358, administered alone or in combination with a second drug named Erlotinib, in…NCT01900652·Birmingham, Alabama and 58 others

CompletedREPLACE: Implantable Cardiac Pulse Generator Replacement RegistryThe objective of this study is to prospectively estimate the all-cause complication rates at 6-months for patients undergoing generator replacement due to elective replacement…NCT00395447·Birmingham, Alabama and 70 others

RecruitingA Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationAge-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time.NCT03178149·Phoenix, Arizona and 19 others

RecruitingSafety and Tolerability Study of GIM-531 in Advanced Solid TumorsGIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy.NCT06425926·Scottsdale, Arizona and 10 others

CompletedStudy Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced ConstipationThis study is designed to evaluate the long-term safety and tolerability of the subcutaneous (SC) injection form of N-methylnaltrexone bromide (MOA-728) for the treatment of…NCT00804141·Birmingham, Alabama and 119 others

RecruitingAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerThis is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancerNCT04614103·Gilbert, Arizona and 70 others

PreviousPage 55 of 954Next

Diabetes

in Tennessee

Heart Diseasein Tennessee